All Categories
Study Investigates an AI-Powered Prognostic Test in Salvage Radiation...
Paul Nguyen discusses the Artera AI prostate test for post-prostatectomy BCR. The test combines clinical factors with AI-anal [...]
Meet the Women Leading the AI Industry: Amanda Lowe...
Amanda Lowe, a recognized leader in digital pathology and artificial intelligence, serves as the Chief Commercial Officer at [...]
Daniel Spratt, MD, on using ArteraAI to guide salvage...
On December 9, 2025, Artera announced the commercial launch of the ArteraAI Prostate Test (Post-RP), a tool designed to help [...]
Development and Validation of a Multimodal Artificial Intelligence–derived Digital...
Biochemical recurrence (BCR) after radical prostatectomy (RP) is a heterogeneous disease state in prostate cancer with multip [...]
Top 10 Urology Times prostate cancer articles of 2025
Times’ top prostate cancer from 2025. Other highly read content included news about the Cleveland Clinic performing the first [...]
Artera Debuts ArteraAI Prostate Test (Post‑RP), Expanding its Oncology...
-Artera, a developer of multimodal AI-based prognostic and predictive cancer tests, today announced the commercial launch of [...]
Artera Unveils Data Demonstrating Prognostic and Predictive Utility in...
First multi-country study validates AI model for risk stratification and chemotherapy prediction SAN FRANCISCO, Nov. 24, 2025 [...]
AI in Oncology Clinical Decision Support
Imagine an oncologist stepping out of tumor board and into clinic with a complex case at hand. The patient’s tumor has multip [...]